Interleukin-18 increases metastasis and immune escape of stomach cancer via the downregulation of CD70 and maintenance of CD44 (original) (raw)

T1637 Gastric Carcinoma Patients Have a Specific Cytokine Profile Characterized By Strongly Increased Levels of Treg Cytokines, IL-1β, IL-6, IL-8 and IL-23 and Decreased Levels of IL-1α, IL-12p70, IFN-γ and TNF-α

Gifone Rocha

Gastroenterology, 2009

View PDFchevron_right

Circulating interleukin-18 (IL-18) is a predictor of response to gemcitabine based chemotherapy in patients with pancreatic adenocarcinoma

Mehmet Karabulut

Journal of Infection and Chemotherapy, 2017

View PDFchevron_right

Interleukin-6 stimulates clonogenic growth of primary and metastatic human colon carcinoma cells

Harald Lahm

Cancer Letters, 2000

View PDFchevron_right

Interleukin-24 is correlated with differentiation and lymph node numbers in rectal cancer

choi youngmin

World Journal of Gastroenterology, 2011

View PDFchevron_right

Immune system: a double-edged sword in cancer

Lakshmi Narendra

Inflammation Research, 2013

View PDFchevron_right

Advanced Colorectal Cancer Is Associated With Enhanced IL-23 and IL-10 Serum Levels

Yovcho Yovtchev

Laboratory Medicine, 2010

View PDFchevron_right

Pathways connecting inflammation and cancer

Cecilia Garlanda

Current Opinion in Genetics & Development, 2008

View PDFchevron_right

Inflammation, atrophy, and gastric cancer

James Fox

Journal of Clinical Investigation, 2007

View PDFchevron_right

Failed immune responses across multiple pathologies share pan-tumor and circulating lymphocytic targets

Nadia Al-Banna

Journal of Clinical Investigation, 2019

View PDFchevron_right

The immunoregulatory mechanisms of carcinoma for its survival and development

Caigan Du

Journal of Experimental & Clinical Cancer Research, 2011

View PDFchevron_right

Diagnostic role of serum interleukin-18 in gastric cancer patients

Varocha Mahachai

World journal of gastroenterology : WJG, 2006

View PDFchevron_right

The dual effects of interleukin-18 in tumor progression

Soyoung Cheon

PubMed, 2007

View PDFchevron_right

Efficacy of multiple anticancer therapies may depend on host immune response

Kritika Karri

Advances in Science, Technology and Engineering Systems Journal, 2017

View PDFchevron_right

Immunonutrition in patients with colon cancer

luis sg

Immunotherapy

View PDFchevron_right

Involvement of IL17A, IL17F and IL23R Polymorphisms in Colorectal Cancer Therapy

ines omrane

PLOS ONE, 2015

View PDFchevron_right

Novel and emerging innate immune therapeutic targets for pancreatic cancer

Imad Shureiqi

Expert Opinion on Therapeutic Targets, 2018

View PDFchevron_right

Clinical and experimental approaches to the pathophysiology of interleukin-18 in cancer progression

Eider Egilegor

Cancer and Metastasis Reviews, 2006

View PDFchevron_right

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two

Roberta Zappasodi

Journal for ImmunoTherapy of Cancer, 2016

View PDFchevron_right

Chemotherapy and immunotherapy of colorectal cancer

Peter Wersäll

Medical Oncology and Tumor Pharmacotherapy, 1991

View PDFchevron_right

Cancer Immunotherapy: A breakthrough in patient care

Abdallah Badou

Health Sciences, 2022

View PDFchevron_right

Malignant T cells activate endothelial cells via IL-17 F

Lise Gjerdrum

Blood Cancer Journal, 2017

View PDFchevron_right

Interleukin-6: Effects on Tumor Models in Mice and on the Cellular Regulation of Transcription Factor IRF-1a

Sheila Harroch

Annals of the New York Academy of Sciences, 2006

View PDFchevron_right

Differential antitumor effect of interleukin-12 family cytokines on orthotopic hepatocellular carcinoma

Chia-Ming Chang

Journal of Gene Medicine, 2010

View PDFchevron_right

Loss of gastrokine-2 drives premalignant gastric inflammation and tumor progression

Toshinari Minamoto

Journal of Clinical Investigation, 2016

View PDFchevron_right

Contributing factors common to COVID‑19 and gastrointestinal cancer

Nikolaos Drakoulis

Oncology Reports, 2021

View PDFchevron_right

IL-33 targeting attenuates intestinal mucositis and enhances effective tumor chemotherapy in mice

Sylvia Amaral

Mucosal Immunology, 2014

View PDFchevron_right

Relevance of Serum Levels of Interleukin-6 and Syndecan-1 in Patients with Hepatocellular Carcinoma

Mamdouh El-Shishtawy

2012

View PDFchevron_right

Immunotherapy: breakthrough in Cancer Treatment

Mrs. Reshmi Gopalakrishnan

2023

View PDFchevron_right

Fas Ligand Promotes Tumor Immune Evasion of Colon Cancer In Vivo

Fergus Shanahan

Cell Cycle, 2006

View PDFchevron_right

mda-7/IL-24: Multifunctional cancer-specific apoptosis-inducing cytokine

PankaJ GupTa

Pharmacology & Therapeutics, 2006

View PDFchevron_right

Lymphocytes CD8+ Expression Mean Increases the Immunity against Cancer

Anita Sari

Journal of Immune Based Therapies, Vaccines and Antimicrobials, 2014

View PDFchevron_right

Aspects of cancer immunotherapy

Bruce Loveland

Immunology and Cell Biology, 2003

View PDFchevron_right

Interleukin-6 Is Required for Pancreatic Cancer Progression by Promoting MAPK Signaling Activation and Oxidative Stress Resistance

Ivy Chung

Cancer Research, 2013

View PDFchevron_right

Signaling pathways bridging microbial-triggered inflammation and cancer

Maulilio Kipanyula

Cellular Signalling, 2013

View PDFchevron_right

Immunotherapy: A Novel Approach to Fight Cancer

Fateh Singh

International Journal of Current Microbiology and Applied Sciences, 2020

View PDFchevron_right